Treatment adherence and its efficacy in real circumstances in patients with first grade arterial hypertension
https://doi.org/10.15829/1728-8800-2016-1-10-15
Abstract
Aim. In patients with arterial hypertension (AH) of 1 grade to find out the effectiveness of blood pressure (BP) control during long-term
observation in real life conditions and to check the factors that might
help with a decision either to prescribe medical treatment or keep on life style modification.
Material and methods. Two times, with the interval 71,3±1,5 months,
66 patients with AH 1 grade were assessed, among those were moderate, moderate-high, high and very high additional cardiovascular risks.
Together with other investigations, all patients at baseline and repeatedly underwent office BP measurement, ambulatory monitoring (ABPM) and body mass check. At primary assessment, the detailed recommendationswere given on the normalization of life style and pharmacotherapy.
During second assessment, the adherence of patients to medical and
life style treatment was evaluated.
Results. With the time, most patients with AH 1 grade had a decrease of BP level, most prominent in patients with higher risk. Only in the highest risk group, there was no BP dynamics. Among all studied, as separately in groups with moderate, moderate-high, high and very high levels, during follow-up there were no differences in BP levels between patients adhering medical therapy and others. The worst adherence was found in moderate risk patients. The best results of body mass index decrease and increase of aerobic physical exercises showed the patients with relatively high glucose level and endothelial vascular factor in blood.
Conclusion. During long-term observation in real circumstances, most
patients with 1 level AH, knowing about medical and non-medical BP
control tools, show its decrease. The level of additional cardiovascular
risk, glucose level and vascular endothelial factor in blood might serve as adherence predictors and treatment effectiveness estimate.
observation in real life conditions and to check the factors that might
help with a decision either to prescribe medical treatment or keep on life style modification.
Material and methods. Two times, with the interval 71,3±1,5 months,
66 patients with AH 1 grade were assessed, among those were moderate, moderate-high, high and very high additional cardiovascular risks.
Together with other investigations, all patients at baseline and repeatedly underwent office BP measurement, ambulatory monitoring (ABPM) and body mass check. At primary assessment, the detailed recommendationswere given on the normalization of life style and pharmacotherapy.
During second assessment, the adherence of patients to medical and
life style treatment was evaluated.
Results. With the time, most patients with AH 1 grade had a decrease of BP level, most prominent in patients with higher risk. Only in the highest risk group, there was no BP dynamics. Among all studied, as separately in groups with moderate, moderate-high, high and very high levels, during follow-up there were no differences in BP levels between patients adhering medical therapy and others. The worst adherence was found in moderate risk patients. The best results of body mass index decrease and increase of aerobic physical exercises showed the patients with relatively high glucose level and endothelial vascular factor in blood.
Conclusion. During long-term observation in real circumstances, most
patients with 1 level AH, knowing about medical and non-medical BP
control tools, show its decrease. The level of additional cardiovascular
risk, glucose level and vascular endothelial factor in blood might serve as adherence predictors and treatment effectiveness estimate.
About the Author
T. A. Mangileva
S. I. Georgievsky Medical Academy of V. I. Vernadsky Crimean Federal University. Simpheropol
Russian Federation
Russian Federation
References
1. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013: DOI:10.1093/eurheartj/eht151
2. Chazova IE, Ratova LG, Boytsov SA, et al. Recommendations for the management of arterial hypertension Russian Medical Society of Arterial Hypertension and Society of Cardiology of the Russian Federation. Cardiologiia 2010; 3: 5-26. (Чазова И.Е., Ратова Л.Г., Бойцов С.А., и др. Диагностика и лечение артериальной гипертензии (рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского общества кардиологов). Кардиология 2010; 3: 5-26).
3. Diao D, Wright JM, Cundiff DK, et al. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev 2012; 8:CD006742. DOI: 10.1002/14651858.CD006742.pub2
4. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-87.
5. Fretheim A, Odgaard-Jensen J, Brors O, et al. Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic revive and multiple treatments meta-analysis. BMC Med 2012; 10: 33.
6. Kobalava GD, Kotovskaya UV, Moiseev VS. Arterial hypertension. The keys to diagnostics and treatment. Moscow: “GEOTAR-Media” 2009, 864 p. Russian (Кобалава Ж.Д., Котовская Ю.В., Моисеев В.С. Артериальная гипертония. Ключи к диагностике и лечению. Москва: «ГЭОТАР-Медиа» 2009; 864 с).
7. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Report From the Panel Members Appointed to the Eighth Joint National Committee (JNС 8). JAMA 2014; 311: 507-20.
8. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JACC 2014; 63: 2960-84.
9. Fryar CD, Gu Q, Ogden CL. Anthropometric reference data for children and adults: United States, 2007-2010. National Center for Health Statistics. Vital Health Stat 2012; 11(252).
10. das Neves VJ, Fernandes T, Roque FR, et al. Exercise training in hypertension: role of microRNAs. World J Cardiol 2014; 6: 713-27.
11. Cornelissen VA, Fagard RH, Coeckelberghs E, et al. Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trails. Hypertension 2011; 58: 950-8.
12. Kalinina AM, Oganov RG, Nebieridze DV. Patients’education as a factor for arterial hypertension effective control – NOCTURNE Program. Cardiovascular Therapy and Prevention 2006; 5(3): 5-14. Russian (Калинина А.М., Оганов Р.Г., Небиеридзе Д.В. Обучение пациентов как фактор эффективного контроля артериальной гипертензии – программа НОКТЮРН. Кардиоваскулярная терапия и профилактика 2006; 5(3): 5-14).
Review
For citations:
Mangileva T.A. Treatment adherence and its efficacy in real circumstances in patients with first grade arterial hypertension. Cardiovascular Therapy and Prevention. 2016;15(1):10-15. (In Russ.) https://doi.org/10.15829/1728-8800-2016-1-10-15
Views:
1218
Email this article 
